World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 15 February 2016
Main ID:  NCT02228018
Date of registration: 25/08/2014
Prospective Registration: Yes
Primary sponsor: FLUIDDA nv
Public title: The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers
Scientific title: The Comparison of Electronic Auscultation Coupled With Computer Aided Lung Sound Analysis (CALSA) and Functional Respiratory Imaging (FRI) and Repeatability of FRI Biomarkers in Healthy Subjects and Asthma Patients
Date of first enrolment: March 2015
Target sample size: 0
Recruitment status: Withdrawn
URL:  https://clinicaltrials.gov/show/NCT02228018
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
Belgium
Contacts
Name:     Wilfried De Backer, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Antwerp
Key inclusion & exclusion criteria

Inclusion Criteria:

- Male or female patient / volunteer = 18 years old

- Written informed consent obtained

- The subject belongs to 1 of the following groups in the opinion of the investigator:

Group 1: healthy volunteer Group 2: patient with asthma

- Only if patient/ volunteer is a female of childbearing potential: Confirmation that a
contraception method was used at least 14 days before visit 1

Exclusion Criteria:

- Pregnant or lactating female

- Patient/ volunteer with an uncontrolled disease or any condition that might, in the
judgement of the investigator, place the patient at undue risk or potentially
compromise the results or interpretation of the study.

Patient/ volunteer with an uncontrolled disease or any condition that might, in the
judgement of the investigator, place the patient at undue risk or potentially compromise
the results or interpretation of the study.



Age minimum: 18 Years
Age maximum: 120 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Asthma
Intervention(s)
Device: CT-scan
Primary Outcome(s)
CALSA [Time Frame: 1 day]
Secondary Outcome(s)
Lobar Volume [Time Frame: 1 day]
Total Airway Resistance (iRaw) [Time Frame: 1 day]
Internal Airway Distribution [Time Frame: 1 day]
Total Airway Volume (iVaw) [Time Frame: 1 day]
Secondary ID(s)
FLUI-2014-118
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history